Accurate,
efficient &
patient-friendly


Non-invasive, painless and immediate liver diagnosis
with quantitative results delivered in real time.

 

Proven liver
fat & stiffness
assessment tools


VCTE™and CAP™ technology documented in over
2,500 peer-reviewed publications worldwide.

 

With over
4,500 systems
worldwide


Echosens has helped support the care
of millions of patients.

WELCOME TO ECHOSENS NORTH AMERICA. WE SPECIALIZE IN NON-INVASIVE, COST-EFFECTIVE TOOLS FOR ASSESSING LIVER HEALTH WITH OUR FIBROSCAN® FAMILY OF PRODUCTS.

Our FibroScan family of products

FibroScan is a pain-free, non-invasive examination of the liver, providing physicians with both liver stiffness and liver fat scores in a single 10-minute procedure. Our FibroScan family of products all come equipped to offer you the same capabilities and examination experience, allowing you the flexibility to choose the size and portability options that suit your needs best.

FibroScan
Unprecedented Mobility for Liver Assessment Efficiency

The FibroScan mini+ is our most portable system, weighing in just over 10lbs, our mini+ is the smallest addition to the FibroScan family of products for access to those who need it most.

Learn more
logo fibroscan 530 compact
Innovation in Liver Disease Management

With its optional roll stand, big 15” touchscreen display, durable yet ergonomic design, the FibroScan Compact is a perfect liver assessment solution for any point-of-care setting.

Learn more

FDA Cleared

FibroScan is the first and only point of care device specifically developed and FDA-Cleared as an aid to the diagnosis and monitoring of adult patients with liver disease. The Shear wave speed stiffness generated by the FibroScan examination may be used as an aid to clinical management of pediatric patients with liver disease.

Learn more about FDA clearance
Dr Nezam Afdhal, Harvard Medical School

Deployed at Beth Israel

"FibroScan is the most effective and best screening test for the diagnosis of chronic liver disease"

Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
See how FibroScan is helping BIDMC

Current media

October 19, 2020 in All, Blog

Rise of Liver Cancer Rates and Link to Non-alcoholic Fatty Liver Disease Highlight Importance of Early Detection

Join us in supporting October 2020 Liver Cancer Awareness Month In the spirit of Liver Cancer Awareness Month this October, Echosens would like to highlight some alarming trends to help…
Read More
September 15, 2020 in Blog

FibroScan and Chronic Care Liver Disease Management

Self-Insured Employers Can Boost Workforce Productivity, Reduce Medical Costs   Download our latest white paper: “Comprehensive Chronic Care Disease Management of Liver Disease Improves Member Outcomes, Reduces Costs for Employer-…
Read More
September 14, 2020 in Blog

Economic Analysis Model Suggests Screening People for Fibrosis With Non-Invasive Tests Cost-effective

NASH Network (NASHNET), a global network of thought leaders dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), has published a novel cost-effectiveness analysis…
Read More

Contact a representative

In North America there are over 1200+ FibroScan systems in operation & we’re growing!

Speak to a Representative